Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Shen, Qingli ^a,c   Cicinnati, Vito R ^a   Zhang, Xiaoyong ^a   Iacob, Speranta ^a,b   Weber, Frank ^a   Sotiropoulos, Georgios C ^a   Radtke, Arnold ^a   Lu, Mengji ^a   Paul, Andreas ^a   Gerken, Guido ^a   Beckebaum, Susanne ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

^c GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISCOIDIN DOMAIN RECEPTOR 1; FIREFLY LUCIFERASE; MICRORNA; MICRORNA 199A 5P; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; DISCOIDIN RECEPTOR; LECTIN RECEPTOR; MIRN199 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL PROLIFERATION; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS C; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MACROVASCULAR INVASION; MALE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING; GENETICS; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MICRORNAS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77955970127     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-227     Document Type: Article

References (51)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002, 31:339-346. 10.1038/ng0802-339, 12149612.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
4. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. 10.1016/j.cell.2004.12.035, 15652477.
5. Lai EC. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002, 30:363-364. 10.1038/ng865, 11896390.
6. Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. Vertebrate microRNA genes. Science 2003, 299:1540. 10.1126/science.1080372, 12624257.
7. miRBase. 2009, http://www.mirbase.org/
8. Singh SK, Pal BM, Girschick HJ, Bhadra U. MicroRNAs--micro in size but macro in function. FEBS J 2008, 275:4929-4944. 10.1111/j.1742-4658.2008.06624.x, 18754771.
9. Meltzer PS. Cancer genomics: small RNAs with big impacts. Nature 2005, 435:745-746. 10.1038/435745a, 15944682.
10. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302:1-12. 10.1016/j.ydbio.2006.08.028, 16989803.
11. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545. 10.1038/sj.onc.1209283, 16331254.
12. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008, 14:419-427. 10.1158/1078-0432.CCR-07-0523, 2755230, 18223217.
13. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008, 47:1223-1232. 10.1002/hep.22158, 18307259.
14. Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang Y, et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008, 283:13205-13215. 10.1074/jbc.M707629200, 18319255.
15. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658. 10.1053/j.gastro.2007.05.022, 17681183.
16. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008, 47:897-907. 10.1002/hep.22160, 18176954.
17. Alves F, Vogel W, Mossie K, Millauer B, Hofler H, Ullrich A. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene 1995, 10:609-618.
18. Vogel W. Discoidin domain receptors: structural relations and functional implications. FASEB J 1999, 13(Suppl):S77-S82.
19. Johnson JD, Edman JC, Rutter WJ. A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain. Proc Natl Acad Sci USA 1993, 90:5677-5681. 10.1073/pnas.90.12.5677, 46784, 8390675.
20. Laval S, Butler R, Shelling AN, Hanby AM, Poulsom R, Ganesan TS. Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line. Cell Growth Differ 1994, 5:1173-1183.
21. Ford CE, Lau SK, Zhu CQ, Andersson T, Tsao MS, Vogel WF. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. Br J Cancer 2007, 96:808-814. 10.1038/sj.bjc.6603614, 2360060, 17299390.
22. Vogel WF, Aszodi A, Alves F, Pawson T. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 2001, 21:2906-2917. 10.1128/MCB.21.8.2906-2917.2001, 86919, 11283268.
23. Park HS, Kim KR, Lee HJ, Choi HN, Kim DK, Kim BT, et al. Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase. Oncol Rep 2007, 18:1435-1441.
24. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 2007, 35:D149-D155. 10.1093/nar/gkl904, 1669779, 17108354.
25. Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 2006, 27:126-139. 10.1016/j.mam.2005.12.003, 16469371.
26. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33:e179. 10.1093/nar/gni178, 1292995, 16314309.
27. Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006, 34:e9. 10.1093/nar/gnj009, 1351374, 16434699.
28. Hellemans J, Mortier G, De PA, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007, 8:R19. 10.1186/gb-2007-8-2-r19, 1852402, 17291332.
29. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:R34.
30. Cicinnati VR, Shen Q, Sotiropoulos GC, Radtke A, Gerken G, Beckebaum S. Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR. BMC Cancer 2008, 8:350. 10.1186/1471-2407-8-350, 2607287, 19036168.
31. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261. 10.1073/pnas.0510565103, 1413718, 16461460.
32. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75:855-862. 10.1016/0092-8674(93)90530-4, 8252622.
33. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006, 20:515-524. 10.1101/gad.1399806, 16510870.
34. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004, 304:594-596. 10.1126/science.1097434, 15105502.
35. Filipowicz W. RNAi: the nuts and bolts of the RISC machine. Cell 2005, 122:17-20. 10.1016/j.cell.2005.06.023, 16009129.
36. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005, 122:553-563. 10.1016/j.cell.2005.07.031, 16122423.
37. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773. 10.1038/nature03315, 15685193.
38. Behm-Ansmant I, Rehwinkel J, Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol 2006, 71:523-530. 10.1101/sqb.2006.71.013, 17381335.
39. Roessler S, Budhu A, Wang XW. Future of molecular profiling of human hepatocellular carcinoma. Future Oncol 2007, 3:429-439. 10.2217/14796694.3.4.429, 17661718.
40. Ongusaha PP, Kim JI, Fang L, Wong TW, Yancopoulos GD, Aaronson SA, et al. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J 2003, 22:1289-1301. 10.1093/emboj/cdg129, 151063, 12628922.
41. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934. 10.1126/science.1149460, 18048652.
42. Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S, et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 2006, 103:17337-17342. 10.1073/pnas.0607015103, 1859931, 17085592.
43. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581. 10.1126/science.1113329, 16141076.
44. Iorio MV, Visone R, Di LG, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67:8699-8707. 10.1158/0008-5472.CAN-07-1936, 17875710.
45. Yu T, Wang XY, Gong RG, Li A, Yang S, Cao YT, et al. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 2009, 28:64. 10.1186/1756-9966-28-64, 2687417, 19435529.
46. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, et al. Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 2008, 14:2535-2542. 10.1158/1078-0432.CCR-07-1231, 18451214.
47. Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A, et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 2009, 33:352-359. 10.1183/09031936.00084108, 19010987.
48. Worley LA, Long MD, Onken MD, Harbour JW. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res 2008, 18:184-190. 10.1097/CMR.0b013e3282feeac6, 18477892.
49. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008, 134:1752-1763. 10.1053/j.gastro.2008.02.090, 18471552.
50. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009, 136:823-837. 10.1016/j.cell.2009.02.024, 2894612, 19269363.
51. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-390. 10.1056/NEJMoa0708857, 18650514.